Berry Global has announced that it will construct a new facility in Bangalore, India that will serve as an R&D center and will add manufacturing capacity for devices, including nasal spray pumps and inhalers, to meet demand in South Asia. Berry already has one manufacturing facility in Bangalore. Berry Global Chairman and CEO Tom Salmon commented, "Investing in … [Read more...] about Berry Global to build new R&D and manufacturing facility in India
Products and Services
H&T Presspart acquires Novelex
H&T Presspart has acquired Swiss device maker Novelex (formerly Forteq Nidau), the company said, and all Novelex employees will be absorbed into H&T Presspart. The company acquired Novelex from Liberta Partners, which had acquired Forteq Nidau in November 2020. Two partners from Liberta Partners, Florian Korp and Peter Franke, commented, "H&T … [Read more...] about H&T Presspart acquires Novelex
Leyden Labs partners with Nanopharm on antiviral nasal spray development
OINDP research and development specialist Nanopharm has partnered with Leyden Labs for development of Leyden Labs antiviral nasal spray candidates, the companies have announced. Nanopharm, which was acquired by Aptar Pharma in 2019, will develop a liquid nasal formulation in preparation for Phase 1 trials and may evaluate a powder formulation as well. In March 2021, … [Read more...] about Leyden Labs partners with Nanopharm on antiviral nasal spray development
Iconovo to provide dry powder nasal device for ISR intranasal COVID-19 vaccine
Device developer Iconovo has received an order worth up to 4.9 million Swedish kronor from Immune System Regulation (ISR) for an intranasal version of Iconovo's ICOone single dose DPI, the company said. In March 2021, Iconovo announced that it had received an order from ISR for development of the ICOone device for a COVID-19 vaccine. The addition of the nasal version … [Read more...] about Iconovo to provide dry powder nasal device for ISR intranasal COVID-19 vaccine
Philip Morris announces £1 billion offer for Vectura
Philip Morris International (PMI) has announced an offer of ~£1.05 billion for the acquisition of inhalation CDMO Vectura. In May 2021, Vectura announced that it would be acquired by the Carlyle Group for £958 million. The Vectura Board has withdrawn its support for the Carlyle deal and agreed to the PMI acquisition, citing PMI's experience with aerosol delivery among … [Read more...] about Philip Morris announces £1 billion offer for Vectura
Inhalation Sciences announces proof-of-concept project with new mouse exposure model
Inhalation Sciences (ISAB) announced that its CRO division, Inhalation Research Services (IRS), has signed an agreement with "an innovative US pharma company that is developing novel mRNA therapies for the treatment of cystic fibrosis and other pulmonary diseases" for a proof-of-concept project utilizing ISAB's PreciseInhale aerosol generating system. The … [Read more...] about Inhalation Sciences announces proof-of-concept project with new mouse exposure model
Copley Scientific joins UK Taskforce for Lung Health Industries Forum
Copley Scientific announced that it has joined the Industries Forum of the UK's Taskforce for Lung Health, and Copley personnel will share their expertise to help advance the taskforce's five-year plan "to improve the nation’s lung health and provide better care for people with lung disease." The company said, "As the world’s leading manufacturer and supplier of … [Read more...] about Copley Scientific joins UK Taskforce for Lung Health Industries Forum
Incannex signs agreement with Vectura for preclinical development of its inhaled CBD/isoflurane for the treatment of TBI
Inhalation CDMO Vectura has announced an agreement to provide preclinical development services for Incannex Healthcare's IHL-216A CBD/isoflurane, which Incannex is developing for the treatment of traumatic brain injury. In addition to performing screening, stability, and optimization studies, Vectura will manufacture the IHL-216A needed for toxicology studies. Monash … [Read more...] about Incannex signs agreement with Vectura for preclinical development of its inhaled CBD/isoflurane for the treatment of TBI
Adherium appoints new CEO, submits 510(k) application for next generation Hailie sensor after rejecting takeover bid
Inhaler monitoring company Adherium has submitted a 510(k) application for a new Hailie sensor designed to work with the Symbicort MDI the company announced. The company recently rejected a takeover bid from another Australian asthma monitoring company called Respiri and then named a new CEO, its sixth chief executive since 2017, saying that it "must continue … [Read more...] about Adherium appoints new CEO, submits 510(k) application for next generation Hailie sensor after rejecting takeover bid
Noveome signs agreement for commercial use of SipNose intranasal device for delivery of ST266
Noveome Biotherapeutics has signed a commercial license agreement for the use of SipNose’s intranasal Cribriform Targeted Device (CT6) for delivery of its ST266 secretome for the treatment of ophthalmological and CNS conditions the companies said. Noveome has been working with SipNose since 2015 and used the device in a Phase 1 trial of ST266 for optic nerve disease … [Read more...] about Noveome signs agreement for commercial use of SipNose intranasal device for delivery of ST266